title: A second-line anti-Helicobacter pylori therapy in patients with previously failed treatment.
authors.forename: A
authors.initials: A
authors.lastname: Ali'
authors.forename: M
authors.initials: M
authors.lastname: Menegatti
authors.forename: L
authors.initials: L
authors.lastname: Gatta
authors.forename: F
authors.initials: F
authors.lastname: Landi
authors.forename: C
authors.initials: C
authors.lastname: Ricci
authors.forename: C
authors.initials: C
authors.lastname: Acciardi
authors.forename: M
authors.initials: M
authors.lastname: Miglioli
authors.forename: D
authors.initials: D
authors.lastname: Vaira
authors.forename: J
authors.initials: J
authors.lastname: Holton
mesh_terms: D000328:Adult; D000368:Aged; D000658:Amoxicillin / Q000008:administration & dosage*; D017291:Clarithromycin / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D018432:Drug Resistance, Multiple; D004359:Drug Therapy, Combination; D005260:Female; D005756:Gastritis / Q000188:drug therapy*; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009853:Omeprazole / Q000008:administration & dosage*; D019233:Retreatment; D017211:Treatment Failure
chemical_list: D000658:Amoxicillin; D017291:Clarithromycin; D009853:Omeprazole